{"id":"W3130302511","doi":"10.1016/j.esmoop.2020.100043","title":"Cediranib in addition to chemotherapy for women with relapsed platinum-sensitive ovarian cancer (ICON6): overall survival results of a phase III randomised trial","year":2021,"lang":"en","type":"article","venue":"ESMO Open","topic":"Ovarian cancer diagnosis and treatment","field":"Medicine","cited_by":29,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Juravinski Cancer Centre","funders":"Medical Research Council; Canadian Cancer Society Research Institute; Cancer Research UK; Cancer Australia; Canadian Cancer Society; AstraZeneca","keywords":"Medicine; Hazard ratio; Internal medicine; Clinical endpoint; Chemotherapy; Placebo; Ovarian cancer; Maintenance therapy; Progression-free survival; Oncology; Randomized controlled trial; Confidence interval; Surgery; Cancer; Pathology","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004762372,0.00135203,0.002471094,0.0004235527,0.0003181236,0.0009759543,0.00080101,0.002010701,0.005084295],"category_scores_gemma":[0.003592752,0.0004902878,0.002608805,0.0005539516,0.0009330657,0.0006711701,0.0005387446,0.002700453,0.0006042154],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008724835,"about_ca_system_score_gemma":0.001092622,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001060699,"about_ca_topic_score_gemma":0.002516882,"domain_scores_codex":[0.9983692,0.00114435,0.00008950005,0.0001669627,0.0001003094,0.0001297683],"domain_scores_gemma":[0.9978435,0.0007600881,0.0005192126,0.0001840506,0.0001172251,0.0005759165],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9812315,0.002101209,0.0005761195,0.0006988086,0.0008449511,0.00002590498,0.00004663522,0.0002307142,0.001103386,0.00006365975,0.0006407053,0.01243644],"study_design_scores_gemma":[0.9551582,0.04077827,0.001840044,0.0000615503,0.0008045968,0.00003946318,0.00001242775,0.0001584263,0.0001791866,0.00006950248,0.0008892003,0.00000910074],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9630066,0.02351274,0.0007330937,0.00161184,0.0008393197,0.004256282,0.002021016,0.0001045688,0.003914521],"genre_scores_gemma":[0.9715809,0.01137272,0.002049708,0.001976815,0.0007756506,0.004580434,0.003483456,0.00003207079,0.004148285],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005084295,"threshold_uncertainty_score":0.02518612,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03323966290094998,"score_gpt":0.3371386250839932,"score_spread":0.3038989621830432,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}